Hydrogen sulfide reduces regional myocardial ischemia injury through protection of mitochondrial function

Xie,Ying‑Hua; Zhang,Nan; Li,Lan‑Fang; Zhang,Qin‑Zeng; Xie,Li‑Jun; Jiang,Hong; Li,Li‑Ping; Hao,Na; Zhang,Jian‑Xin

doi:10.3892/mmr.2014.2391

Hydrogen sulfide reduces regional myocardial ischemia injury through protection of mitochondrial function

Authors:
- Ying‑Hua Xie
- Nan Zhang
- Lan‑Fang Li
- Qin‑Zeng Zhang
- Li‑Jun Xie
- Hong Jiang
- Li‑Ping Li
- Na Hao
- Jian‑Xin Zhang
View Affiliations

Affiliations: Department of Pharmacology, Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China, Department of Pharmacology, Hebei Academy of Medical Sciences, Shijiazhuang, Hebei 050021, P.R. China
Published online on: July 17, 2014 https://doi.org/10.3892/mmr.2014.2391
Pages: 1907-1914

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hydrogen sulfide (H2S) is a signaling gasotransmitter, involved in various physiological and pathological processes. H2S‑donating drugs have been tested to conjugate the beneficial effects of H2S with other pharmaceutical properties. It has been shown that the endogenous cystathionine‑γ‑lyase (CSE)/H2S pathway participates in myocardial ischemia injury in isolated hearts in rats. The present study aimed to investigate the cytoprotective action of H2S against acute myocardial ischemia injury in rats. Isolated rat hearts were perfused and subjected to ischemic conditions for 4 h. The hearts were assigned to five groups: Sham, model, infarct plus low‑dose (5 µmol/l) NaHS, infarct plus middle‑dose (10 µmol/l) NaHS and infarct plus high‑dose (20 µmol/l) NaHS. The administration of NaHS enhanced the activity of CSE, increased the content of H2S and reduced infarct volumes following myocardial ischemia injury. Furthermore, the administration of NaHS attenuated the injury to organelles (including the mitochondria, nucleus and myofilaments) by reducing lactate dehydrogenase activity, decreasing the level of mitochondrial malondialdehyde and increasing the activities of superoxide dismutase and glutathione peroxidase in the ischemic myocardial mitochondria. These protective effects of H2S against myocardial ischemia injury appeared to be mediated by its antioxidant activities and the preservation of mitochondrial function.

View Figures

View References

1	Thom T, Haase N, Rosamond W, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 113:e85–e151. 2006. View Article : Google Scholar : PubMed/NCBI
2	Nabel EG and Braunwald E: A tale of coronary artery disease and myocardial infarction. N Engl J Med. 366:54–63. 2012. View Article : Google Scholar : PubMed/NCBI
3	Mathers CD and Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3:e4222006. View Article : Google Scholar : PubMed/NCBI
4	Lloyd-Jones D, Adams RJ, Brown TM, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation. 121:e46–e215. 2010. View Article : Google Scholar : PubMed/NCBI
5	Renda G and de Caterina R: Impact of antiplatelet therapy in heart disease. Adv Cardiol. 47:5–19. 2012. View Article : Google Scholar : PubMed/NCBI
6	Gnecchi M, Danieli P and Cervio E: Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol. 57:48–55. 2012. View Article : Google Scholar : PubMed/NCBI
7	Songco AV and Brener SJ: Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature. Curr Cardiol Rep. 14:397–407. 2012. View Article : Google Scholar
8	Bhind R, Witting PK, McMahon AC, Khachigian LM and Lowe HC: Rat models of myocardial infarction. Pathogenetic insights and clinical relevance. Thromb Haemost. 96:602–610. 2006.PubMed/NCBI
9	Langendorff O: Untersuchungen am überlebenden Säugethierherzen. Arch Ges Physiol. 61:291–332. 1895.
10	Skrzypiec-Spring M, Grotthus B, Szelag A and Schulz R: Isolated heart perfusion according to Langendorff - still viable in the new millennium. J Pharmacol Toxicol Methods. 55:113–126. 2007. View Article : Google Scholar : PubMed/NCBI
11	Wang R: Two’s company, three’s a crowd: can H₂S be the third endogenous gaseous transmitter? FASEB J. 16:1792–1798. 2002.
12	Ignarro LJ, Buga GM, Wood KS, Byrns RE and Chaudhuri G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 84:9265–9269. 1987. View Article : Google Scholar : PubMed/NCBI
13	Palmer RM, Ferrige AG and Moncada S: Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature. 327:524–526. 1987. View Article : Google Scholar : PubMed/NCBI
14	Marks GS, Brien JF, Nakatsu K, et al: Does carbon monoxide have a physiological function? Trends Pharmacol Sci. 12:185–188. 1991. View Article : Google Scholar : PubMed/NCBI
15	Verma A, Hirsch DJ, Glatt CE, et al: Carbon monoxide: a putative neural messenger. Science. 259:381–384. 1993. View Article : Google Scholar : PubMed/NCBI
16	Abe K and Kimura H: The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci. 16:1066–1071. 1996.PubMed/NCBI
17	Pearson RJ, Wilson T and Wang R: Endogenous hydrogen sulfide and the cardiovascular system-what’s the smell all about? Clin Invest Med. 29:146–150. 2006.
18	Szabó C: Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov. 6:917–935. 2007.
19	Jha S, Calvert JW, Duranski MR, Ramachandran A and Lefer DJ: Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. Am J Physiol Heart Circ Physiol. 295:H801–H806. 2008. View Article : Google Scholar : PubMed/NCBI
20	Bos EM, Leuvenink HG, Snijder PM, et al: Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephrol. 20:1901–1905. 2009. View Article : Google Scholar : PubMed/NCBI
21	Wang MJ, Cai WJ, Li N, Ding YJ, Chen Y and Zhu YC: The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia. Antioxid Redox Signal. 12:1065–1077. 2010. View Article : Google Scholar : PubMed/NCBI
22	Zhang Z, Huang H, Liu P, Tang C and Wang J: Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening K ATP channels. Can J Physiol Pharmacol. 85:1248–1253. 2007. View Article : Google Scholar : PubMed/NCBI
23	Ji Y, Pang QF, Xu G, Wang L, Wang JK and Zeng YM: Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Eur J Pharmacol. 587:1–7. 2008. View Article : Google Scholar
24	Sodha NR, Clements RT, Feng J, et al: The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg. 33:906–913. 2008. View Article : Google Scholar : PubMed/NCBI
25	Sivarajah A, Collino M, Yasin M, et al: Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock. 31:267–274. 2009. View Article : Google Scholar : PubMed/NCBI
26	Lavu M, Bhushan S and Lefer DJ: Hydrogen sulfide-mediated cardioprotection: mechanisms and therapeutic potential. Clin Sci (Lond). 120:219–229. 2011.PubMed/NCBI
27	Liu H, Yan J, Xu YW, Bai XJ and Wu BW: Modification of ex-vivo ischemia/reperfusion modeling in isolated rat heart. Chinese Remedies & Clinics. 7:586–587. 2007.(In Chinese).
28	Stipanuk MH and Beck PW: Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J. 206:267–277. 1982.PubMed/NCBI
29	Hwa JS, Jin YC, Lee YS, et al: 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction. J Ethnopharmacol. 139:605–615. 2012.
30	Shiva S, Brookes PS and Darley-Usmar VM: Methods for measuring the regulation of respiration by nitric oxide. Methods Cell Biol. 80:395–416. 2007. View Article : Google Scholar : PubMed/NCBI
31	Abe K and Kimura H: The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci. 16:1066–1071. 1996.PubMed/NCBI
32	Geng B, Yang J, Qi Y, Zhao J, Pang Y, Du J and Tang C: H₂S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun. 313:362–368. 2004.
33	Li L, Rose P and Moore PK: Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol. 51:169–187. 2011. View Article : Google Scholar
34	Chen P, Poddar R, Tipa EV, et al: Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease. Adv Enzyme Regul. 39:93–109. 1999. View Article : Google Scholar : PubMed/NCBI
35	Szabó C: Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov. 6:917–935. 2007.
36	Zhao W, Zhang J, Lu Y and Wang R: The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J. 20:6008–6016. 2001. View Article : Google Scholar : PubMed/NCBI
37	Geng B, Chang L, Pan C, et al: Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun. 318:756–763. 2004. View Article : Google Scholar : PubMed/NCBI
38	Jiang HL, Wu HC, Li ZL, Geng B and Tang CS: Changes of the new gaseous transmitter H₂S in patients with coronary heart disease. Di Yi Jun Yi Da Xue Xue Bao. 25:951–954. 2005.(In Chinese).
39	Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S and Moore PK: Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther. 316:670–678. 2006. View Article : Google Scholar : PubMed/NCBI
40	Yong QC, Pan TT, Hu LF and Bian JS: Negative regulation of beta-adrenergic function by hydrogen sulphide in the rat hearts. J Mol Cell Cardiol. 44:701–710. 2008. View Article : Google Scholar : PubMed/NCBI
41	Tokuda K, Kida K, Marutani E, et al: Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice. Antioxid Redox Signal. 17:11–21. 2012. View Article : Google Scholar
42	Jiang LH, Luo X, He WA, Huang XX and Cheng TT: Effects of exogenous hydrogen sulfide on apoptosis proteins and oxidative stress in the hippocampus of rats undergoing heroin withdrawal. Arch Pharm Res. 34:2155–2162. 2011. View Article : Google Scholar : PubMed/NCBI
43	Ytrehus K: The ischemic heart - experimental models. Pharmacol Res. 42:193–203. 2000. View Article : Google Scholar
44	Kelly PJ, Kistler JP, Shih VE, et al: Inflammation, homocysteine, and vitamin B6 status after ischemic stroke. Stroke. 35:12–15. 2004. View Article : Google Scholar : PubMed/NCBI
45	Diwakar L and Ravindranath V: Inhibition of cystathionine-gamma-lyase leads to loss of glutathione and aggravation of mitochondrial dysfunction mediated by excitatory amino acid in the CNS. Neurochem Int. 50:418–426. 2007. View Article : Google Scholar : PubMed/NCBI
46	Blaustein A, Deneke SM, Stolz RI, Baxter D, Healey N and Fanburg BL: Myocardial glutathione depletion impairs recovery after short periods of ischemia. Circulation. 80:1449–1457. 1989. View Article : Google Scholar : PubMed/NCBI
47	Dombkowski RA, Russell MJ and Olson KR: Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am J Physiol Regul Integr Comp Physiol. 286:R678–R685. 2004. View Article : Google Scholar : PubMed/NCBI
48	Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S and Moore PK: Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther. 316:670–678. 2006. View Article : Google Scholar : PubMed/NCBI
49	Hosoki R, Matsuki N and Kimura H: The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun. 237:527–531. 1997. View Article : Google Scholar : PubMed/NCBI
50	Nie LH, Zhou YZ, Ding J, et al: Effects of matrine on infarct size and ultramicrostructure in rats with acute myocardial ischemic injury. Ningxia Med J. 33:292–294. 2011.(In Chinese).
51	Yang GD, Wu LY, Jiang B, et al: H₂S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science. 322:587–590. 2008.
52	Wang R: Hydrogen sulfide: a new EDRF. Kidney Int. 76:700–704. 2009. View Article : Google Scholar : PubMed/NCBI
53	Murry CE, Richard VJ, Reimer KA and Jennings RB: Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 66:913–931. 1990. View Article : Google Scholar
54	Flameng W, Andres J, Ferdinande P, Mattheussen M and Van Belle H: Mitochondrial function in myocardial stunning. J Mol Cell Cardiol. 23:1–11. 1991. View Article : Google Scholar
55	Lesnefsky EJ, Tandler B, Ye J, Slabe TJ, Turkaly J and Hoppel CL: Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am J Physiol. 273:H1544–H1554. 1997.
56	Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J and Hoppel CL: Mitochondrial dysfunction in cardiac disease: ischemia - reperfusion, aging, and heart failure. J Mol Cell Cardiol. 33:1065–1089. 2001. View Article : Google Scholar : PubMed/NCBI
57	Lowell BB and Shulman GI: Mitochondrial dysfunction and type 2 diabetes. Science. 307:384–387. 2005. View Article : Google Scholar : PubMed/NCBI
58	Roden M: Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes. Int J Obes (Lond). 29(Suppl 2): S111–S115. 2005. View Article : Google Scholar : PubMed/NCBI
59	Hardy L, Clark JB, Darley-Usmar VM, Smith DR and Stone D: Reoxygenation-dependent decrease in mitochondrial NADH:CoQ reductase (Complex I) activity in the hypoxic/reoxygenated rat heart. Biochem J. 274:133–137. 1991.PubMed/NCBI
60	Liu F, Zhang JX, Li LF, Zhang QZ, Ding YY and Zhang XY: Effects of hydrogen sulfide on myocardial mitochondrial injury during acute myocardial ischemia in rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 27:158–162. 2011.(In Chinese).
61	Crystal GJ, Malik G, Yoon SH and Kim SJ: Isoflurane late preconditioning against myocardial stunning is associated with enhanced antioxidant defenses. Acta Anaesthesiol Scand. 56:39–47. 2012. View Article : Google Scholar